Signaling molecules with either attractive or repulsive effects on specific growth cones are likely to play a role in guiding axons to their appropriate targets. A chick brain glycoprotein, collapsin, has been shown to be a good candidate for a repulsive guidance cue. We report here the discovery of four new molecules related to collapsin in chick brains. All contain a semaphorin domain. One is structurally very similar to collapsin but is only 50% identical in its amino acid sequence. We have named it collapsin-2. The collapsinrelated genes exhibit distinct but overlapping patterns of mRNA expression in the developing spinal cord and the developing visual system. This family of collapsinrelated molecules could potentially act as repulsive cues toward specific neuronal populations.
Introduction
Axonal growth cones are guided through the developing embryo by their specific responses to a variety of attractive and repulsive guidance cues (Raper et al., 1988; Goodman and Shatz, 1993) . A good candidate for a repulsive guidance cue is the glycoprotein collapsin. Collapsin induces the paralysis of growth cone motility and the collapse of normal growth cone morphology in vitro (Luo et al., 1993) . Several lines of evidence suggest that collapsin could serve as a repulsive signaling molecule in axon pathfinding events. First, its inhibitory action is specific to particular growth cone types in vitro; for example, inhibiting sensory growth cone motility at concentrations that have no effect on retinal ganglion cell growth cones. Second, sensory growth cones will turn to avoid small beads to which collapsin has been cova~ently bound (Fan and Raper, 1995) . Third, collapsin expression is specifically localized in the developing CNS (t. S., Y. L., J. A. R., and S. C., submitted). Fourth, a portion of collapsin is related to the growth cone guidance molecule fasciclin IV/semaphorin I (Kolodkin et al., 1992) . Finally, collapsin is extremely potent, active at concentrations around 10 pM (Luo et al., 1993) . This very high specific activity suggests that the collapsing signal is likely to be transduced through a receptor-mediated signal transduction mechanism. Consistent with this hypothesis is the observation that sensory growth cones often turn away from collapsin-coated beads, even when only the tips of their filopodia touch the beads (Fan and Raper, 1995) .
These findings have led to a model of collapsin action in which the interaction of collapsin with a ceil surface receptor activates an intracellular signaling pathway whose effects can spread within the growth cone (Fan and Raper, 1995) . Weak activation of the signaling pathway leads to a localized inhibition of net actin polymerization and a local diminution in lamellar advance. This local inhibition of advance alongside the more normal rates of lamellar extension in the rest of the growth cone causes the growth cone to extend away from a localized repulsive stimulus. Stronger or less localized activation of the signaling pathway leads to a net loss of fibrillar actin throughout the growth cone, and its wholesale collapse and paralysis. Several different growth cone-collapsing activities have been described. Some of these activities must be mediated by distinct molecules, since they either are differentially localized or affect different growth cone types. Some examples include a cue on peripheral axons that induces the collapse of retinal ganglion cell growth cones but has no effect on peripheral growth cones (Kapfhammer and Raper, 1987) . A separate cue is found on only nasal retinal axons that, unlike the peripheral cue that affects all retinal ganglion cell growth cones, induces the collapse of only temporal retinal ganglion cell growth cones (Raper and Grunewald, 1990) . Still another cue on both nasal and temporal retinal axons induces the collapse of peripheral growth cones (Kapfhammer and Raper, 1987) . These patterns of specificity demonstrate that each activity is distinct and indicate that each is likely to be mediated by a different repulsive cue. Many more collapsing cues have been described in a variety of systems (Cox et al., 1990; Davies et al., 1990; Moorman and Hume, 1990) , many of which are likely to represent additional independent molecules. One particularly important example is the inhibitory activity expressed by oligodendrocytes, which has been hypothesized to interfere with axonal regeneration in the mature CNS Caroni and Schwab, 1988; Vanselow et al., 1990; Fawcett et al., 1989) . The wide variety of growth cones and motile cell types affected by this activity distinguish it from the more specific activities just described.
It seems reasonable that some of these collapseinducing cues may be closely related to one another and display target specificities toward specific populations of neuronal growth cones. The biochemical purification and molecular cloning of collapsin provided strong evidence for this hypothesis (Luo et al., 1993) . Even highly enriched native collapsin was found to induce the collapse of both sensory and retinal ganglion cell growth cones, while recombinant collapsin induced the collapse of only sensory growth cones. One interpretation of these results is that another biochem ically related molecule with retinal growth cone-collapsing activity copurified with collapsin during the biochemical enrichment. It therefore seemed reasonable to use the cDNA sequence of collapsin to search for related cDNAs that might encode novel proteins with new collapsing specificities.
Here we report the discovery of a molecule that is structurally very similar to collapsin, but whose amino acid sequence is only about 50% identical to that of collapsin. We also report the partial sequences of three additional molecules related to collapsin. We show that these collapsin-related molecules exhibit distinct patterns of mRNA expression in the developing CNS and in the periphery. A family of differentially distributed, collapsin-related proteins has recently been discovered independently in the mouse (PDschel et al., 1995). These findings establish the existence of a family of molecules related to collapsin in the developing vertebrate CNS.
Results

The Identification of Molecules Related to Collapsin
To identify collapsin-related molecules, we screened a chick brain cDNA library at both low and high stringencies using collapsin cDNA as a probe. One cDNA clone was identified that hybridized with the collapsin probe at low but not high stringencies. This cDNA contains a partial open reading frame that predicts a novel protein homologous to collapsin. This candidate protein was therefore named collapsin-2, and the original collapsin has been renamed collapsin-1. The full-length collapsin-2 cDNA was (A) An alignment comparing the predicted amino acid sequences of chick collapsin-1 and collapsin-2 was generated by the Align module of the Pearson sequence analysis package (Myers and Miller, 1988) . All amino acid residues shared in collapsin-1 and collapsin-2 are shaded. All conserved cysteine residues are marked by asterisks, and all asparagine residues likely to be glycosylated are marked by plus signs. The 2 extra cysteine residues in collapsin-2 are underlined. The positions of amino acid residues are given at the right.
(B) The amino acid sequences at the C-terminal ends of the semaphorin domains are aligned for the chick collapsin family members 1-5 and Drosophila semaphorin I and semaphorin II. All amino acid residues shared by four or more members of this group are shaded. All the conserved cysteine residues ere marked by asterisks. The primer sequences used to generate the PCR fragments of collapsin-3, collapsin-4, and collapsin-5 sequences are not included. They were DDKIYFFF at the N-terminal end and DPYCAWD at the C-terminal end. The positions of amino acid residues are given at the right.
obtained through additional library screening and polymerase chain reaction (PCR) cloning using the available collapsin-2 sequence information. To identify additional relatives of these two molecules, we synthesized two degenerate oligonucleotide primers encoding protein sequences conserved in collapsin-1 and collapsin-2. These two primers were used for PCR amplification of cDNAs prepared from El0 chick brain mRNA. An apparent 0.9 kb PCR product corresponding to the predicted size between the two primers was obtained ard subcloned into a plasmid vector. The cDNA clones were screened with the collapsin-1 and collapsin-2 probes at both low and high stringencies, and those that hybridized at low but not high stringencies were isolated. DNA sequencing analysis showed that three of the isolated cDNA inserts contain open reading frames encoding novel proteins related to collapsin. The cDNA sequence for collapsin-2 predicts a protein of 761 amino acids, with a molectJlar mass of 87 kDa and a pl of 8.6. The deduced protein sequence contains two potential sites for N-linked glycosylation. Collapsin-2 is homologous to collapsin-1 throughout its length ( Figure 1A ). The overall amino acid identity between collapsin-2 and collapsin-1 is about 49%. In cor~trast, the overall amino acid identity between chick collapsin-1 and human semaphorin III/collapsin-1 is about 88o/~. If the cysteine residues in the signal peptide sequences are ignored, 18 cysteine residues are conserved among human collapsin-1, chick collapsin-1, and chick collapsin-2. An additional 2 cysteine residues are found in the N-terminal region of collapsin-2.
Collapsin-2 has a structural arrangement similar to that of collapsin-1 (Figure 2 ). Like collapsin-1, collapsin-2 also contains a signal peptide sequence for protein secretion at the N-terminus but no transmembrane domain. The signal peptide cleavage site is predicted to be at Gly-24 (von Heijne, 1986) . In addition, the N-terminal half of collapsin-2 also shares a significant homology with that of fasciclin IV (renamed semaphorin I), a growth cone guidance protein in grasshopper (Kolodkin et al., 1992) . The overall amino acid identity between collapsin-2 and collapsin-1 within this region is about 60%. The C-terminal half of collapsin-2 contains an immunoglobulin-like domain of the C2 type (61% identity with collapsin-1) and a highly basic C-terminal region (42% identity with collapsin-1). In contrast, the overall amino acid identities between human coilapsin-1 and chick coilapsin-1 in these three regions are 93%, 78%, and 87%, respectively ( Figure 2 ).
The cDNA sequences for coilapsin-3, collapsin-4, and collapsin-5 predict protein sequences that share significant homologies with those of collapsin-1 and collapsin-2 at the 3' end of the fasciclin IV-like semaphorin domain (Figure 1 B; Figure 2 ). All cysteine residues are conserved among the five members of the collapsin family, with the exception of an additional cysteine residue at position 219 in collapsin-3 and the replacement of a cysteine residue at position 315 with valine in collapsin-4 (see Figure 1B ). In this region, collapsin-1, collapsin-2, collapsin-3, and collapsin-5 resemble each other with average amino acid identities of 57% among the four members (Table 1) . Collapsin-4 appears to be more distantly related, sharing an average amino acid identity of 34% with the other four members. In this part of the semaphorin domain, the amino acid sequences of the five collapsin-like molecules appear to be equally divergent from Drosophila semaphorin I and semaphorin II, sharing an average amino acid identity of 28%.
Distribution of Collapsin-2 mRNA in the Developing Chick Spinal Cord and Limb Buds
A digoxigenin-labeled antisense RNA probe complementary to the full coding sequence of collapsin-2 was generated and used to examine the distribution of collapsin-2 mRNA in the developing chick nervous system and limb buds between Hamburger and Hamilton (1951) Schematic comparison of human semaphorin Ul/collapsin-1, chick collapsin-1 and collapsin-2, the partial sequences of the chick coUapsin-related sequences 3-5, and Drosophila semaphorin I and semaphorin II. The percentages of identitical amino acids within homologous domains of human semaphorin III, chick collapsin-1, and chick collapsin-2 are shown. The dashed line marks the region of the semaphorin domain where amino acid sequence identities are compared in Table 1 . The symbols identifying each domain are given at the left. Collapsin-2 expression is detectable at high levels throughout the dorsal third of the spinal cord and along its entire rostrocaudal length at stage 14 ( Figure 3A ). The only portion of the dorsal cord that does not hybridize with the probe is the roof plate. Intense hybridization is also seen in the floor plate along the entire rostrocaudal length of the spinal cord. The notochord expresses collapsin-2 message at this stage but at lower levels than the dorsal cord and floor plate. No expression is observed in the adjacent somitic mesoderm. Some expression is detected in the epidermis just dorsal to the spinal cord. Between stages 14 and 20, the expression of collapsin-2 in the dorsal spinal cord is gradually restricted even more dorsally. By stage 20, collapsin-2 message is expressed in two small groups of cells on either side of the roof plate ( Figure  3B ). Expression within the floor plate remains at a high level along its entire extent during this period. By stage 24, hybridization drops to undetectable levels in the dorsal cord ( Figure 3C ). Expression is now seen in the presumptive motor neuron pools in the ventral horns. Message is also detected in a group of ventricular cells within the ventral half of the cord, and expression continues in the floor plate. A similar but more intense pattern of expression is observed at stage 28 ( Figure 3D ). In addition, a few expressing cells are seen along the lateral edges of the gray matter extending to the dorsal root entry zone. Outside of the spinal cord, the dorsal root ganglia are seen to express collapsin-2 message for the first time (data not shown), and the dermamyotome contains weakly expressing cells, By stage 30, there is a differential expression of collapsin-2 message in the different spinal motor columns ( Figure 3E ). Outside the spinal cord, the expression of collaspin-2 message within the dorsal root ganglia begins to be restricted ventrally. The condensing spinal vertebrae also start to express message weakly. By stage 34, the pattern of staining within the cord is unchanged but becomes more intense ( Figure 3F ). Collapsin-2 expression in the dorsal root ganglia has been further restricted to the ventral-and lateral-most part of each ganglion. Around the outside of the dorsal part of the cord, strongly expressing cells are seen ventrally around the motor nerve root exit point, in the pia, and in the vertebrae. By stage 45, a small number of collapsin-2-positive cells is seen dispersed throughout the gray and white matter of the spinal cord (data not shown). The overall level of collapsin-2 expression is much lower than at earlier stages.
Collapsin-2 is specifically distributed in the developing limbs. At stage 28, nonneuronal cells within the peripheral nerve contain a number of collapsin-2-positive cells that may be Schwann cells ( Figure 3G ). In the limb buds, the cleaving dorsal and ventral muscle masses are seen to express collapsin-2, as do the margins of the limb bones ( Figure 3H ). By stage 34 in the limb, muscles and bones continue to express collapsin-2, though some muscles appear more intensely stained than others (data not shown).
Comparison of the Distributions of Collapsin-1, Collapsin-2, and Collapsin-5 mflNAs in the Spinal Cord
Collapsin family members are differentially localized in the developing spinal cord. Digoxigenin-labeled antisense mRNA probes complementary to the full coding sequences of collapsin-1 and collapsin-2, and to the partial sequences of collapsin-3, collapsin-4, and collapsin-5, were used to probe sections of stage 18 chick spinal cords. Only probes to collapsin-1, collapsin-2, and collapsin-5 gave detectable hybridization signals on the sections (Figure 4) . At this stage of development, collapsin-1 is expressed in the demamyotome but not within the cord. Collapsin-2 expression is detectable in the floor plate and in the cells adjoining the roof plate. Outside the nervous system, the dermamyotome does not express collapsin-2, but intense expression is detected in the dorsal limb epidermis (data not shown). Collapsin-5 expression is detected in the dorsal cord on either" side of the roof plate, in laterally situated cells within the ventral cord, and in the floor plate. The demamyotomes also express collapsin-5 mRNA.
Distribution of Collapsin-2 mRNA in the Developing Visual System of the Chick
The expression of collapsin-2 was investigated in the developing retina, optic nerve, and tectum. At stage 36 (El 0), collapsin-2 message is expressed throughout the central and peripheral retina in a lamina-specific manner. This expression is restricted to the inner nuclear layer and to a small number of retinal ganglion cells ( Figure 5A ). At the optic nerve head and in the optic nerve, no expression is seen, but the pecten and the mesoderm surrounding the optic nerve close to the eye give a strong hybridization signal ( Figure 5C to the optic nerve head, but none are present in the peripheral retina. Most striking at this stage are a large number of collapsin-2-expressing nonneuronal cells at the optic nerve head and in the optic nerve ( Figure 5D ).
Collapsin-2 expression in the tectum was examined in E l 0 embryos. This is the time when the first optic axons begin to innervate the optic tectum. Collapsin-2 expression is distributed in a clear anterior-posterior gradient, with high levels of expression in the anterior tectum as compared with the posterior tectum ( Figure 5E ). This ex-pression pattern is consistent with the previously described anterior-posterior gradient of maturation of the tectum (LaVail and Cowan, 1971) . The expression in the tectum is laminar specific. Collapsin-2 is expressed just below the ingrowing retinal fibers in the stratum opticum (SO), in a sublayer within the stratum griseum et fibrosum superficiale (SGFS), and in the superficial portion of the stratum griseum centrale (SGC~ ( Figure 5B ).
Discussion
We have begun to characterize a family of molecules related to the growth cone-collapsing protein collapsin/collapsin-1. Previously, related molecules have been reported in a variety of species from flies to humans (Kolodkin et al., 1993) . Most or atl of these previously discovered proteins are likely to be species homologs of either collapsin-1 or the transmembrane protein fasciclin IV/ semaphorin I. The very high identity in amino acid sequences between chick collapsir~-I and human semaphorin III strongly suggests that the two are homologous proteins. Apparent fasciclin IV/semaphorin I homologs have been identified in three separate insect species. The only previously described molecule that may not be a species homolog of collapsin-1 or semaphorin I is the Drosophila protein semaphorin I1. Its structure is similar to that of collapsin-1, but its sequence is relatively dissimilar. The long evolutionary distance between insects and vertebrates makes it difficult to determine whether the two are species homologs or different related molecules.
Here we show that a number of clearly distinct relatives of collapsin-1 can be found within the same vertebrate species, confirming the existence of a larger protein family. Since we have the full sequence for only one of these relatives, we do not know how many of them have domain structures analogous to that of collapsin-1 or, in contrast, analogous to the transmembrane protein semaphorin I. Collapsin-2, however, has a structure that is clearly similar to that of collapsin-1. A signal peptide sequence is followed by a long stretch of sequence related to all of the semaphorin family members. As in collapsin-1, this sequence similarity ends abruptly with the conserved sequence DPYCAWD. This sequence also marks the point of divergence between Drosophila semaphorin land the Drosophila collapsin-like semaphorin I1. This conserved sequence may therefore mark a conserved break between the N-terminal semaphorin domain and the adjacent immunoglobulin-containing domain of collapsin family members. Both collapsin-1 and collapsin-2 have highly basic amino acid sequences at their C-terminal ends. Although these sequences are only 42% identical, they contain a stretch of 14 of 18 identical amino acids (residues 756-774). This stretch accounts for almost all of the identities between the basic tails of the two proteins. This sequence may represent a motif with functional importance, possibly serving to bind both collapsins to specific sites on the cell surface, the extracellular matrix, or their receptors.
The structural similarities between the two collapsins suggest that they share important functional properties.
We hypothesize that collapsin-1 functions as a signaling molecule that provides guidance information to specific extending growth cones in vivo. Consistent with this view are the inhibitory effects of collapsin-1 on sensory but not retinal growth cones, the ability of collapsin-l-coated beads to alter the trajectories of cultured sensory growth cones, and the similarity between collapsin-1 and the grasshopper axon guidance molecule semaphorin I. The high divergence of the collapsin-I and collapsin-2 sequences, along with the similarity between their overall domain structures, suggests that collapsin-2 may also be a growth cone guidance molecule, but that it may have a differing specificity in its interactions with target growth cones. Might collapsin-2, like collapsin-1, be a repulsive guidance cue? The demonstrated inhibitory effects of collapsin-1 (Luo et al., 1993) and semaphorin III (Messersmith et al., 1995) and the possible inhibitory effects of semaphorin I (Kolodkin et al., 1993) implicate the semaphorin domain-containing molecules in repulsive interactions. This line of reasoning predicts that collapsin-2 will also be a repulsive guidance cue. However, if one considers these molecules to be signaling molecules, the responses of target growth cones may depend upon the receptors they express and the context in which the signal is interpreted. Thus, some or all of these family members may ultimately be shown to function as growth cone repulsors, as growth cone attractors, or as signals influencing biological events unrelated to growth cone guidance.
If the collapsins are to provide guidance information, they must be specifically distributed in some locations and not others within the developing nervous system. We have recently shown that collapsin-1 mRNA is distributed in such a manher. It is localized in specific neuronal and nonneuronal populations in the developing CNS and periphery (1. S., Y. L., J. A. R., and S. C., submitted). The distribution of collapsin-1 mRNA suggests some specific instances in which it could play a role in axon guidance. For example, significant collapsin-1 message is expressed in the ventral spinal cord, making collapsin-1 a likely candidate for an activity that has previously been shown to be secreted by ventral cord explants and which, like collapsin-1, repulses sensory growth cones (Fitzgerald et al., 1993; Messersmith et al., 1995) . Collapsin-1 may therefore play a role in confining sensory axons or terminations within appropriate regions of the spinal cord.
Collapsin-2 mRNA is also specifically localized within the spinal cord, but in a different pattern from that of collapsin-1. Collapsin-2 message is first expressed in the dorsal half of the cord and in the floor plate, two regions that never express significant collapsin-1 mRNA. Later, collapsin-2 mRNA is found in cells within the ventral horns, a location in which collapsin-1 mRNA is expressed somewhat later in development. The two messages are therefore expressed in distinct but overlapping patterns. Interestingly, collapsin-5 is also expressed in the spinal cord, and its pattern of expression is different from those of collapsin-1 and collapsin-2. The overlapping distributions of these likely signaling molecules could serve as the basis for a guidance system based on regions in which specific combinations of guidance cues are selectively expressed.
The dorsal distribution of collapsin-2 in the early cord suggests that it could play a role in patterning interneuron axon outgrowth. Previous work has shown that the trajectories of commissural interneurons are partially determined by cues emanating from the ventral midline (Tessier-Lavigne et al., 1988; Placzek et al., 1990; Yaginuma and Oppenheim, 1991) . A chemoattractant for dorsal commissural interneurons, netrin-1, has been shown to be produced in the floor plate of the cord Kennedy et al., 1994) ; however, netrin-1 probably does not impose the initial ventral direction on commissural outgrowth. In the Danforth mutant mouse, in which the floor plate is absent in the caudal part of the spinal cord, commissural axons continue to extend ventrally, even though netrin-1 -expressing floor plate cells would be expected to be absent (Bovolenta and Dodd, 1991) . This raises the possibility that at least one other cue in the dorsal cord has an immediate orienting effect on commissural axons. Collapsin-2 expression is localized in approximately the correct location and at the correct time to help orient the axon trajectories of ventrally extending interneurons. Collapsin-2 is expressed in the dorsal third of the cord at stage 14, just prior to the time at which the first of these cells in the dorsal half of the cord begin to elaborate their axons ventrally (Yaginuma et al., 1990) . If collapsin-2 acts as a soluble repulsor for these axons, it could help to drive them toward the ventral midline. Alternatively, collapsin-2 or collapsin-5 could help to control which of these ventrally extending axons cross at the midline. Since interactions between ventrally extending axons and the floor plate are likely to influence which axons cross the m idline and which do not (Bernhardt et al., 1992) , the presence of collapsin-2 and collapsin-5 makes them possible candidate repulsors for axons that remain ipsilateral to the midline.
The distribution of collapsin-2 in the tectum suggests that it could help to organize the normal extension of retinal afferents into appropriate retinorecipient layers. In the chick, the tectum is the primary target for retinal ganglion cell axons. Retinal afferents first arrive at the tectum around E6, but they do not invade the outer tectal layers until E9-E10 (reviewed in Mey and Thanos, 1992) . The retinal axons first course over the most superficial margin of the tectum in the SO and then dive into deeper layers. Terminals form in two discrete sublayers within the SGFS (LaVail and Cowan, 1971) . Recent studies have shown that explanted retinal ganglion cells preferentially extend on those portions of tectal slices that correspond to the SO and the retinorecipient regions of the SG FS . In theory, retinal axons could prefer growing within these layers because of the presence of specific neurite-promoting molecules within them (Kroger and Schwarz, 1990; Krushel et al., 1993; Lagunowich et al., 1992; Lemmon and McLoon, 1986; Redies et al., 1993; , or instead, they may avoid repulsive cues in the nonpreferred layers while extending on generally distributed permissive cues. The pattern of collapsin-2 hybridization observed in El0 tectal sections--weak expression just below the SO, expression dividing the SGFS, and expression in the superficial portion of the nonretinorecipient SGC-resembles those portions of the tectum that do not promote retinal outgrowth and do not receive retinal terminations. It is therefore attractive to hypothesize that collapsin-2 helps to exclude retinal axons from nonretinorecipient tectal layers.
The presence of collapsin-2 in the E20 optic nerve may be an important impediment to retinal ganglion cell regeneration. When the optic nerve is crushed in rats, a large percentage of retinal ganglion cells die (Villegas-Perez et al., 1988) . These cells can be rescued by injecting braindervied neurotrophic factor into the eye (Mansour-Robaey et al., 1994) . Although axons from the rescued cells grow profusely within the eye, they do not enter the optic nerve head and therefore do not extend into a peripheral nerve grafted onto the stump of the optic nerve (MansourRobaey et al., 1994) . One possible interpretation of these observations is that a repulsor localized to the optic nerve head prevents retinal ganglion cell axons from entering the nerve. The collapsin-2-expressing nonneuronal cells in the optic nerve and optic nerve head of the late stage chick eye appear to be appropriately positioned to provide such a cue.
Previous work has shown that inhibitory cues associated with oligodendrocytes are likely to prevent the growth of axons within the optic nerve and other white matter (Schwab and Thoenen, 1985; Schwab, 1988, 1989) . Oligodend rocytes are unlikely to provide a repulsive cue to regenerating ganglion cell axons within the rat retina, however, since the lamina cribrosa in the rat optic nerve is thought to prevent oligodendrocytes and their precusors from migrating into the retina (Perry and Lund, 1990; ffrench-Constant et al., 1988) . In contrast, retinal ganglion cell axons are myelinated in the chick retina (Kohsaka et al., 1983) , and it is therefore possible that the collapsin-2-expressing cells we see are oligodendrocytes. The presence of collapsin-2-positive cells in the white matter of the E20 cord may also be consistent with the possibility that collapsin-2 is expressed in oligodendrocytes. Determining whether or not this is the case will require double labeling studies with probes for collapsin-2 and specific nonneuronal cell types.
Our observations indicate that there exists a family of molecules related to the growth cone-collapsing molecule collapsin-l. One of these, collapsin-2, has a striking structural resemblance to collapsin-1. This resemblance suggests that collapsin-2 could also be a repulsive guidance molecule, but the significant differences between the two collapsin sequences raise the possibility that they affect different sets of growth cones. If the axons of ventrally extending spinal interneurons are shown to be repelled by collapsin-2, the dorsal distribution of collapsin-2 in the cord could help direct the ventral extension of these axons. Alternatively, the presence of collapsin-2 in the floor plate could help to determine which interneurons cross the ventral midline. If retinal ganglion cell axons are shown to be repelled by collapsin-2, collapsin-2 could help organize retinal extension and termination in the optic tectum, and might also be responsible for the observed failure of retinal ganglion cell axons to regenerate into the optic nerve.
These possible functions of coilapsin-2 can be tested in the future.
Experimental Procedures
Cloning of Additional Members of the Collapsin Family
The NotI-Xbal DNA fragment coding for the entire collapsin-1 sequence (Luo et al., 1993) was used to generate probes by random priming (Feinberg and Vogelstein, 1983) . The probe was used to screen an adult chicken brain cDNA ~ibrary in bacteriophage Zgtl0 (Clontech) at low stringency (45°C in 6x SSC, 5o/0 Blotto). After the identification of hybridizing plaques, the same filter was rescreened at high stringency (65°C in 6 x SSC, 5°/o BIotto). One phage clone wasidentifiedfromthescreeningof2 x 106 phage plaques. This clone hybridized with the coUapsin probe at low but not high stringencies. The cloned cDNA encodes a portion of a novel protein that is homologous to collapsin-1. We named this putative protein collapsin-2. The remaining 5' end of collapsin-2 was isolated through library screening using radiolabeled oligonucleotide probes that were based upon the 5'-most end of the available cDNA sequence. The remaining 3' end of collapsin-2 was isolated by PCR cloning. The template for the PCR reactions was a single-stranded cDNA synthesized from El0 chick brain mRNA using Moloney murine leukemia virus reverse transcriptase and random primers. Two rounds of PCR using two nested primers corresponding to the 3'-most end of the available cDNA sequence and an oligo(dT)15 primer generated a 0.6 kb PCR fragment coding for the ramaining 3'end of collapsin-2. The 3' end of collapsin-2 was generated once again by PCR from the single-stranded cDNA synthesized from El0 chick brain mRNA, using one primer corresponding to the 3'-most end of the available cDNA sequence and another primer derived from the 3' end of :he 0.6 kb PCR fragment. This PCR product was used to complete the collapsin-2 sequence.
Additional collapsin relatives were identified by PCR. The PCR template was single-stranded cDNA synthesized from El0 chick brain mRNA using Moloney murine leukemia virus reverse transcriptase and random primers. Two degenerate cligonucleotides encoding conserved protein sequences between coilapsin-1 and collapsin-2 were synthesized and used as PCR primers. They are the sense primer 5'-GA(CT)G A(CT)AA(AG)AT(ACT)TA(CT)TF(CT)'I-F(C "F)TT-3', coding for the peptide sequence DDKYIFFF, and the antisanse primer 5'-TCCCANGC(AG)CA(AG)TANGG(AG)TC-3', coding for the peptide sequence DPYCAWD. The conditions for the PCR reaction were as follows: an initial 2 min at 94°C followed by 35 cycles of 94°C for 40 s, 45°C for 1 min, and 74°C for 1 rain, and a final incubation at 74°C for 9 rain. One major PCR band running at 0.9 kb in agarose gels was identified that corresponds to the predicted collapsin fragment size for the two primers used. This PCR product was isolated and subcloned into the pCR-II vector using the TA cloning kit (Invitrogen) . Using a similar screening procedure for the identification of collapsin-2 cDNA, several clones were isolated that hybridized with collapsin-1 and collapsin-2 probes at low but not high stringencies, These clones were shown to contain sequences coding for three additional relatives of collapsin-l.
DNA Sequence Analysis
Nucleotide sequences were determined by the dideoxy chain termination method (Sanger et al., 1977) using double-stranded DNA as template and T7 DNA polymerase (Sequenase, US Biochemicals). Both strands of the cDNA inserts were sequenced using synthetic oligonucleotides as primers. Searches for related sequences were done through the BLAST network service provided by the National Center for Biotechnology Information.
Preparation of Dlgoxigenin-Labeled RNA Probes
Probes were generated using a procedure derived from that of Schaeran-Wiemers and Gerfin-Moser (1993) . Transcription reactions were carried out essentially as recommended by Boehringer Mannhelm. The digoxigenin-labeled RNA probes were precipitated and subjected to mild alkaline hydrolysis in 60 mM Na~CO3, 40 mM NaHCO3 (pH 10.2) for 1 hr at 60°C to reduce the probe length to around 200 bp.
In Situ Hybridizations on Tissue Sections
All embryonic tissues were fixed in 4% paraformaldehyde overnight at 4°C. The hybridization buffer was 50% formamide, 4x SSC, 1 x Denhardt's, 10% dextran sulfate, and 0.5 mg/ml salmon sperm DNA. Most washes were carried out in 0.3% Triton X-100 in PBS; the blocking buffer for the antibody incubations was 10% fetal calf serum, 0.3% Triton X-100 in PBS; and the alkaline phosphatase reaction buffer was 100 mM Tris (pH 9.5), 50 mM MgCI2, 100 mM NaCI, 0.1o/0 Tween 20, and 1 mM levamisole. The hybridization procedures for tissue sections were derived from those of Kennedy et al. (1994) . Fixed embryos were cryoprotected in 20% sucrose and frozen in TissueTek OCT embedding medium compound. Sections (30 p.m) were cut on a Jung CM3000 cryostat and collected on Superfrost Plus slides (Fisher). All incubations were carried out at room temperature unless otherwise stated. Sections were washed in PBS, acetylated for 10 min (3.5 ml of triethanolamine and 0.75 ml of acetic anhydride in 300 ml of distilled H20), and parmeabilized in PBS with 1O/o Triton X-100. Sections were prehybridizad for 6 hr, then hybridized with digoxigeninderivatized probes (0.4 p.g/ml) overnight at 72°C. The next day, slides were washed with 0.2x SSC for 60 min at 72°C and briefly rinsed in fresh 0.2x SSC. Slides were then washed with PBS, blocked in blocker for 1 hr, incubated with alkaline phosphatase--conjugated anti-DIG antibody (1:5000) in blocker for 1 hr, rinsed with PBS, incubated in alkaline phosphatase reaction buffer, and then reacted for 1 hr to 2 days with 0.33 mg/ml nitroblue tetrozolium and 0.t 7 mg/ml 5-bromo-4-chloro-indolylphosphate toluidinium in the dark.
